Pulmonx Corp (LUNG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 122,178 | 129,399 | 148,711 | 188,306 | 198,934 |
| Marketable Securities | 40,139 | 40,914 | 31,561 | 11,774 | 10,774 |
| Receivables | 7,521 | 6,810 | 6,562 | 6,919 | 6,884 |
| Inventories | 19,212 | 18,304 | 16,285 | 14,985 | 13,401 |
| TOTAL | $192,781 | $200,725 | $208,002 | $227,644 | $233,084 |
| Non-Current Assets | |||||
| PPE Net | 4,932 | 4,918 | 4,814 | 4,703 | 2,773 |
| Investments And Advances | 4,684 | 6,379 | 10,941 | 2,798 | 2,024 |
| Intangibles | 2,549 | 2,580 | 2,610 | 2,641 | 2,672 |
| Other Non-Current Assets | 7,783 | 8,247 | 8,806 | 9,032 | 8,387 |
| TOTAL | $19,948 | $22,124 | $27,171 | $19,174 | $15,856 |
| Total Assets | $212,729 | $222,849 | $235,173 | $246,818 | $248,940 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,306 | 1,889 |
| Accounts payable and accrued liabilities | 2,599 | 2,803 | 1,582 | 4,434 | 2,156 |
| Accrued Expenses | 11,734 | 10,872 | 13,366 | 12,374 | 10,499 |
| Other current liabilities | 2,921 | 798 | 91 | N/A | N/A |
| TOTAL | $20,446 | $17,715 | $17,550 | $22,217 | $16,326 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,460 | 16,629 | 17,324 | 13,547 | 14,938 |
| Deferred Revenues | 131 | 132 | 163 | 157 | 85 |
| Other Non-Current Liabilities | 5,594 | 6,307 | 7,023 | 8,156 | 7,685 |
| TOTAL | $20,101 | $22,989 | $24,384 | $21,773 | $22,694 |
| Total Liabilities | $40,547 | $40,704 | $41,934 | $43,990 | $39,020 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,268 | 37,117 | 37,019 | 36,839 | 36,690 |
| Common Shares | 37 | 37 | 37 | 37 | 36 |
| Retained earnings | -321,863 | -307,223 | -291,395 | -278,389 | -267,156 |
| Other shareholders' equity | 1,357 | 1,443 | 1,712 | 1,544 | 1,479 |
| TOTAL | $172,182 | $182,145 | $193,239 | $202,828 | $209,920 |
| Total Liabilities And Equity | $212,729 | $222,849 | $235,173 | $246,818 | $248,940 |